Dr Brian Koffman The Role Of MRD Testing In His Treatment Decision April 2020

You are here:

Home
The Basics
MRD & Disease Monitoring
Dr Brian Koffman The Role Of MRD Testing In His Treatment Decision April 2020

May 4, 2020

What is MRD Testing? When is it Done? What can it tell us? Find out how Dr. Koffman relied on the results of his post-CAR-T clonoSEQ MRD testing in his decision to stop taking ibrutinib after nearly 8 years.

About the author

Brad Hedrick

CLL Advocates Network (CLLAN) September 30, 2020 Webinar
November 1, 2020

ASH 2019: Dr. Siddiqi Discusses a Clinical Trial of Lisocel®, a CAR-T Therapy for CLL
October 30, 2020

ASH 2019: Dr. Sameer Parikh on Monoclonal B-cell Lymphocytosis, a Precursor to Chronic Lymphocytic Leukemia (CLL)
October 16, 2020

iwCLL 2019: Dr. Andy Rawstron on minimal residual disease (MRD) testing for chronic lymphocytic leukemia (CLL)
September 24, 2020

MRD Glossary
September 4, 2020

ASH 2019 MRD Testing: Dr. Chaitra Ujjani’s short video explains the concept of MRD testing and its value in predicting progression free survival.
August 27, 2020